{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CLTA-4", "PD-L1", "UHRF1", "immune escape", "pseudogene"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31442209", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "02"}, "DateRevised": {"Year": "2020", "Month": "09", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "08", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10.18632/aging.102197"], "Journal": {"ISSN": "1945-4589", "JournalIssue": {"Volume": "11", "Issue": "16", "PubDate": {"Year": "2019", "Month": "Aug", "Day": "23"}}, "Title": "Aging", "ISOAbbreviation": "Aging (Albany NY)"}, "ArticleTitle": "A disparate role of RP11-424C20.2/UHRF1 axis through control of tumor immune escape in liver hepatocellular carcinoma and thymoma.", "Pagination": {"StartPage": "6422", "EndPage": "6439", "MedlinePgn": "6422-6439"}, "Abstract": {"AbstractText": ["The immune system is critical in modulating cancer progression. Pseudogenes are a special type of long non-coding RNAs that regulate different tumorigenic processes. However, the potential roles of pseudogenes in tumor-immune interaction remain largely unclear. Here, we reported that pseudogene RP11-424C20.2 and its parental gene UHRF1 were frequently up-regulated and positively correlated in liver hepatocellular carcinoma (LIHC) and thymoma (THYM), but associated with distinct clinical outcomes. We further found that RP11-424C20.2 may act as a competing endogenous RNA (ceRNA) to increase UHRF1 expression through sponging miR-378a-3p. Functional enrichment analysis showed a strong association of UHRF1 with immune-related biological processes. We also observed that UHRF1 expression significantly correlated with immune infiltration, and different types of tumor-infiltrating immune cells displayed different impacts on clinical outcomes. Furthermore, UHRF1 expression in LIHC and THYM showed an opposite correlation with biomarkers from monocyte, dendritic cell, Th1 and T cell exhaustion. Mechanism investigations revealed that RP11-424C20.2/UHRF1 axis regulated immune escape of LIHC and THYM at least partly through IFN-\u03b3-mediated CLTA-4 and PD-L1 pathway. These findings demonstrate a disparate role of RP11-424C20.2/UHRF1 axis in LIHC and THYM via regulating immune infiltrates, and also indicate a therapeutic value for UHRF1 inhibitors in combination with anti-PD-L1/CLTA-4 blockade."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Endemic and Ethnic Diseases (Guizhou Medical University), Ministry of Education, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": ", The Key Laboratory of Medical Molecular Biology (Guizhou Medical University), Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}], "LastName": "Yang", "ForeName": "Jue", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urology, Guizhou Province People's Hospital, Guiyang 550002, China."}], "LastName": "Zhang", "ForeName": "Yongqiang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Endemic and Ethnic Diseases (Guizhou Medical University), Ministry of Education, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": ", The Key Laboratory of Medical Molecular Biology (Guizhou Medical University), Guiyang 550004, China."}], "LastName": "Song", "ForeName": "Hui", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Aging (Albany NY)", "NlmUniqueID": "101508617", "ISSNLinking": "1945-4589"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers, Tumor"}, {"RegistryNumber": "0", "NameOfSubstance": "CCAAT-Enhancer-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN378 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Long Noncoding"}, {"RegistryNumber": "EC 2.3.2.27", "NameOfSubstance": "UHRF1 protein, human"}, {"RegistryNumber": "EC 2.3.2.27", "NameOfSubstance": "Ubiquitin-Protein Ligases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Biomarkers, Tumor"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "CCAAT-Enhancer-Binding Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Genotype"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Prognosis"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA, Long Noncoding"}, {"QualifierName": ["metabolism"], "DescriptorName": "Thymoma"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Ubiquitin-Protein Ligases"}, {"QualifierName": [], "DescriptorName": "Up-Regulation"}], "CoiStatement": "<b>CONFLICTS OF INTEREST:</b> The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J, Wu J, Li M. MicroRNA-374a activates Wnt/\u03b2-catenin signaling to promote breast cancer metastasis. J Clin Invest. 2013; 123:566\u201379. 10.1172/JCI65871", "ArticleIdList": ["10.1172/JCI65871", "PMC3561816", "23321667"]}, {"Citation": "Zhen Y, Fang W, Zhao M, Luo R, Liu Y, Fu Q, Chen Y, Cheng C, Zhang Y, Liu Z. miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin. Oncogene. 2017; 36:275\u201385. 10.1038/onc.2016.201", "ArticleIdList": ["10.1038/onc.2016.201", "27270423"]}, {"Citation": "Wu H, Liu Y, Shu XO, Cai Q. MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression. Carcinogenesis. 2016; 37:567\u201375. 10.1093/carcin/bgw038", "ArticleIdList": ["10.1093/carcin/bgw038", "PMC4876989", "27207663"]}, {"Citation": "Zhao M, Xu P, Liu Z, Zhen Y, Chen Y, Liu Y, Fu Q, Deng X, Liang Z, Li Y, Lin X, Fang W. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/\u03b2-catenin signaling in non-small-cell lung cancer. Cell Death Dis. 2018; 9:78. 10.1038/s41419-017-0103-7", "ArticleIdList": ["10.1038/s41419-017-0103-7", "PMC5833350", "29362431"]}, {"Citation": "Ott PA, Hodi FS, Robert C. CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients. Clin Cancer Res. 2013; 19:5300\u201309. 10.1158/1078-0432.CCR-13-0143", "ArticleIdList": ["10.1158/1078-0432.CCR-13-0143", "24089443"]}, {"Citation": "Rotte A, Jin JY, Lemaire V. Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy. Ann Oncol. 2018; 29:71\u201383. 10.1093/annonc/mdx686", "ArticleIdList": ["10.1093/annonc/mdx686", "29069302"]}, {"Citation": "Poliseno L. Pseudogenes: newly discovered players in human cancer. Sci Signal. 2012; 5:re5. 10.1126/scisignal.2002858", "ArticleIdList": ["10.1126/scisignal.2002858", "22990117"]}, {"Citation": "Xiao-Jie L, Ai-Mei G, Li-Juan J, Jiang X. Pseudogene in cancer: real functions and promising signature. J Med Genet. 2015; 52:17\u201324. 10.1136/jmedgenet-2014-102785", "ArticleIdList": ["10.1136/jmedgenet-2014-102785", "25391452"]}, {"Citation": "Kong Y, Zhang L, Huang Y, He T, Zhang L, Zhao X, Zhou X, Zhou D, Yan Y, Zhou J, Xie H, Zhou L, Zheng S, Wang W. Pseudogene PDIA3P1 promotes cell proliferation, migration and invasion, and suppresses apoptosis in hepatocellular carcinoma by regulating the p53 pathway. Cancer Lett. 2017; 407:76\u201383. 10.1016/j.canlet.2017.07.031", "ArticleIdList": ["10.1016/j.canlet.2017.07.031", "28823960"]}, {"Citation": "Hendrickson RC, Cicinnati VR, Albers A, Dworacki G, Gambotto A, Pagliano O, T\u00fcting T, Mayordomo JI, Visus C, Appella E, Shabanowitz J, Hunt DF, DeLeo AB. Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide. Cancer Immunol Immunother. 2010; 59:113\u201324. 10.1007/s00262-009-0730-7", "ArticleIdList": ["10.1007/s00262-009-0730-7", "PMC2855844", "19562340"]}, {"Citation": "Moreau-Aubry A, Le Guiner S, Labarri\u00e8re N, Gesnel MC, Jotereau F, Breathnach R. A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma. J Exp Med. 2000; 191:1617\u201324. 10.1084/jem.191.9.1617", "ArticleIdList": ["10.1084/jem.191.9.1617", "PMC2213434", "10790436"]}, {"Citation": "Song H, Yang J, Zhang Y, Zhou J, Li Y, Hao X. Integrated analysis of pseudogene RP11-564D11.3 expression and its potential roles in hepatocellular carcinoma. Epigenomics. 2019; 11:267\u201380. 10.2217/epi-2018-0152", "ArticleIdList": ["10.2217/epi-2018-0152", "30362374"]}, {"Citation": "Sidhu H, Capalash N. UHRF1: the key regulator of epigenetics and molecular target for cancer therapeutics. Tumour Biol. 2017; 39:1010428317692205. 10.1177/1010428317692205", "ArticleIdList": ["10.1177/1010428317692205", "28218043"]}, {"Citation": "Xie S, Qian C. The Growing Complexity of UHRF1-Mediated Maintenance DNA Methylation. Genes (Basel). 2018; 9:E600. 10.3390/genes9120600", "ArticleIdList": ["10.3390/genes9120600", "PMC6316679", "30513966"]}, {"Citation": "Patnaik D, Est\u00e8ve PO, Pradhan S. Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development. Oncotarget. 2018; 9:26243\u201358. 10.18632/oncotarget.25425", "ArticleIdList": ["10.18632/oncotarget.25425", "PMC5995235", "29899856"]}, {"Citation": "Ashraf W, Ibrahim A, Alhosin M, Zaayter L, Ouararhni K, Papin C, Ahmad T, Hamiche A, M\u00e9ly Y, Bronner C, Mousli M. The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer. Oncotarget. 2017; 8:51946\u201362. 10.18632/oncotarget.17393", "ArticleIdList": ["10.18632/oncotarget.17393", "PMC5584303", "28881702"]}, {"Citation": "Alhosin M, Omran Z, Zamzami MA, Al-Malki AL, Choudhry H, Mousli M, Bronner C. Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer. J Exp Clin Cancer Res. 2016; 35:174. 10.1186/s13046-016-0453-5", "ArticleIdList": ["10.1186/s13046-016-0453-5", "PMC5108085", "27839516"]}, {"Citation": "Beck A, Trippel F, Wagner A, Joppien S, Felle M, Vokuhl C, Schwarzmayr T, Strom TM, von Schweinitz D, L\u00e4ngst G, Kappler R. Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma. Clin Epigenetics. 2018; 10:27. 10.1186/s13148-018-0462-7", "ArticleIdList": ["10.1186/s13148-018-0462-7", "PMC5833129", "29507645"]}, {"Citation": "Taniue K, Kurimoto A, Sugimasa H, Nasu E, Takeda Y, Iwasaki K, Nagashima T, Okada-Hatakeyama M, Oyama M, Kozuka-Hata H, Hiyoshi M, Kitayama J, Negishi L, et al.. Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1. Proc Natl Acad Sci USA. 2016; 113:1273\u201378. 10.1073/pnas.1500992113", "ArticleIdList": ["10.1073/pnas.1500992113", "PMC4747749", "26768845"]}, {"Citation": "Liu X, Ou H, Xiang L, Li X, Huang Y, Yang D. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma. Oncotarget. 2017; 8:10510\u201322. 10.18632/oncotarget.14446", "ArticleIdList": ["10.18632/oncotarget.14446", "PMC5354676", "28060737"]}, {"Citation": "He H, Lee C, Kim JK. UHRF1 depletion sensitizes retinoblastoma cells to chemotherapeutic drugs via downregulation of XRCC4. Cell Death Dis. 2018; 9:164. 10.1038/s41419-017-0203-4", "ArticleIdList": ["10.1038/s41419-017-0203-4", "PMC5833858", "29415984"]}, {"Citation": "Ivashkiv LB. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018; 18:545\u201358. 10.1038/s41577-018-0029-z", "ArticleIdList": ["10.1038/s41577-018-0029-z", "PMC6340644", "29921905"]}, {"Citation": "Garcia-Diaz A, Shin DS, Moreno BH, Saco J, Escuin-Ordinas H, Rodriguez GA, Zaretsky JM, Sun L, Hugo W, Wang X, Parisi G, Saus CP, Torrejon DY, et al.. Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression. Cell Rep. 2017; 19:1189\u2013201. 10.1016/j.celrep.2017.04.031", "ArticleIdList": ["10.1016/j.celrep.2017.04.031", "PMC6420824", "28494868"]}, {"Citation": "Wen YZ, Zheng LL, Qu LH, Ayala FJ, Lun ZR. Pseudogenes are not pseudo any more. RNA Biol. 2012; 9:27\u201332. 10.4161/rna.9.1.18277", "ArticleIdList": ["10.4161/rna.9.1.18277", "22258143"]}, {"Citation": "An Y, Furber KL, Ji S. Pseudogenes regulate parental gene expression via ceRNA network. J Cell Mol Med. 2017; 21:185\u201392. 10.1111/jcmm.12952", "ArticleIdList": ["10.1111/jcmm.12952", "PMC5192809", "27561207"]}, {"Citation": "Li RK, Gao J, Guo LH, Huang GQ, Luo WH. PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer. Cancer Gene Ther. 2017; 24:309\u201315. 10.1038/cgt.2017.29", "ArticleIdList": ["10.1038/cgt.2017.29", "28731027"]}, {"Citation": "Gao L, Ren W, Zhang L, Li S, Kong X, Zhang H, Dong J, Cai G, Jin C, Zheng D, Zhi K. PTENp1, a natural sponge of miR-21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma. Mol Carcinog. 2017; 56:1322\u201334. 10.1002/mc.22594", "ArticleIdList": ["10.1002/mc.22594", "27862321"]}, {"Citation": "Yu G, Yao W, Gumireddy K, Li A, Wang J, Xiao W, Chen K, Xiao H, Li H, Tang K, Ye Z, Huang Q, Xu H. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol Cancer Ther. 2014; 13:3086\u201397. 10.1158/1535-7163.MCT-14-0245", "ArticleIdList": ["10.1158/1535-7163.MCT-14-0245", "PMC4265235", "25249556"]}, {"Citation": "Chen R, Zhang M, Liu W, Chen H, Cai T, Xiong H, Sheng X, Liu S, Peng J, Wang F, Chen H, Lin W, Xu X, et al.. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma. Cell Death Dis. 2018; 10:4. 10.1038/s41419-018-1207-4", "ArticleIdList": ["10.1038/s41419-018-1207-4", "PMC6315040", "30584245"]}, {"Citation": "Zhang ZY, Zhu B, Zhao XW, Zhan YB, Bao JJ, Zhou JQ, Zhang FJ, Yu B, Liu J, Wang YM, Bai YH, Hong J, Liu XZ. Regulation of UHRF1 by microRNA-378 modulates medulloblastoma cell proliferation and apoptosis. Oncol Rep. 2017; 38:3078\u201384. 10.3892/or.2017.5939", "ArticleIdList": ["10.3892/or.2017.5939", "28901497"]}, {"Citation": "Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012; 12:298\u2013306. 10.1038/nrc3245", "ArticleIdList": ["10.1038/nrc3245", "22419253"]}, {"Citation": "Zhang H, Liu H, Shen Z, Lin C, Wang X, Qin J, Qin X, Xu J, Sun Y. Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer. Ann Surg. 2018; 267:311\u201318. 10.1097/SLA.0000000000002058", "ArticleIdList": ["10.1097/SLA.0000000000002058", "27763900"]}, {"Citation": "Waniczek D, Lorenc Z, \u015anietura M, Wesecki M, Kopec A, Muc-Wierzgo\u0144 M. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer. Arch Immunol Ther Exp (Warsz). 2017; 65:445\u201354. 10.1007/s00005-017-0463-9", "ArticleIdList": ["10.1007/s00005-017-0463-9", "PMC5602054", "28343267"]}, {"Citation": "Rosenthal R, Cadieux EL, Salgado R, Bakir MA, Moore DA, Hiley CT, Lund T, Tani\u0107 M, Reading JL, Joshi K, Henry JY, Ghorani E, Wilson GA, et al., and TRACERx consortium. Neoantigen-directed immune escape in lung cancer evolution. Nature. 2019; 567:479\u201385. 10.1038/s41586-019-1032-7", "ArticleIdList": ["10.1038/s41586-019-1032-7", "PMC6954100", "30894752"]}, {"Citation": "Allison JP. Immune Checkpoint Blockade in Cancer Therapy: The 2015 Lasker-DeBakey Clinical Medical Research Award. JAMA. 2015; 314:1113\u201314. 10.1001/jama.2015.11929", "ArticleIdList": ["10.1001/jama.2015.11929", "26348357"]}, {"Citation": "Chen L, Han X. Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest. 2015; 125:3384\u201391. 10.1172/JCI80011", "ArticleIdList": ["10.1172/JCI80011", "PMC4588282", "26325035"]}, {"Citation": "Zhang J, Dang F, Ren J, Wei W. Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy. Trends Biochem Sci. 2018; 43:1014\u201332. 10.1016/j.tibs.2018.09.004", "ArticleIdList": ["10.1016/j.tibs.2018.09.004", "PMC6252278", "30287140"]}, {"Citation": "Walker LS, Sansom DM. Confusing signals: recent progress in CTLA-4 biology. Trends Immunol. 2015; 36:63\u201370. 10.1016/j.it.2014.12.001", "ArticleIdList": ["10.1016/j.it.2014.12.001", "PMC4323153", "25582039"]}, {"Citation": "Cerezo M, Guemiri R, Druillennec S, Girault I, Malka-Mahieu H, Shen S, Allard D, Martineau S, Welsch C, Agoussi S, Estrada C, Adam J, Libenciuc C, et al.. Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma. Nat Med. 2018; 24:1877\u201386. 10.1038/s41591-018-0217-1", "ArticleIdList": ["10.1038/s41591-018-0217-1", "30374200"]}, {"Citation": "Mo X, Zhang H, Preston S, Martin K, Zhou B, Vadalia N, Gamero AM, Soboloff J, Tempera I, Zaidi MR. Interferon-\u03b3 Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4. Cancer Res. 2018; 78:436\u201350. 10.1158/0008-5472.CAN-17-1615", "ArticleIdList": ["10.1158/0008-5472.CAN-17-1615", "PMC5771950", "29150430"]}, {"Citation": "Parker BS, Rautela J, Hertzog PJ. Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer. 2016; 16:131\u201344. 10.1038/nrc.2016.14", "ArticleIdList": ["10.1038/nrc.2016.14", "26911188"]}, {"Citation": "Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, et al.. NKp46 Receptor-Mediated Interferon-\u03b3 Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis. Immunity. 2018; 48:107\u2013119.e4. 10.1016/j.immuni.2017.12.007", "ArticleIdList": ["10.1016/j.immuni.2017.12.007", "29329948"]}, {"Citation": "Benci JL, Xu B, Qiu Y, Wu TJ, Dada H, Twyman-Saint Victor C, Cucolo L, Lee DS, Pauken KE, Huang AC, Gangadhar TC, Amaravadi RK, Schuchter LM, et al.. Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade. Cell. 2016; 167:1540\u20131554.e12. 10.1016/j.cell.2016.11.022", "ArticleIdList": ["10.1016/j.cell.2016.11.022", "PMC5385895", "27912061"]}, {"Citation": "Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012; 12:252\u201364. 10.1038/nrc3239", "ArticleIdList": ["10.1038/nrc3239", "PMC4856023", "22437870"]}, {"Citation": "Nirschl CJ, Su\u00e1rez-Fari\u00f1as M, Izar B, Prakadan S, Dannenfelser R, Tirosh I, Liu Y, Zhu Q, Devi KS, Carroll SL, Chau D, Rezaee M, Kim TG, et al.. IFN\u03b3-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment. Cell. 2017; 170:127\u2013141.e15. 10.1016/j.cell.2017.06.016", "ArticleIdList": ["10.1016/j.cell.2017.06.016", "PMC5569303", "28666115"]}, {"Citation": "Aspeslagh S, Morel D, Soria JC, Postel-Vinay S. Epigenetic modifiers as new immunomodulatory therapies in solid tumours. Ann Oncol. 2018; 29:812\u201324. 10.1093/annonc/mdy050", "ArticleIdList": ["10.1093/annonc/mdy050", "29432557"]}, {"Citation": "Dunn J, Rao S. Epigenetics and immunotherapy: the current state of play. Mol Immunol. 2017; 87:227\u201339. 10.1016/j.molimm.2017.04.012", "ArticleIdList": ["10.1016/j.molimm.2017.04.012", "28511092"]}, {"Citation": "Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A, Makarov V, Budhu S, Slamon DJ, et al.. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell. 2015; 162:974\u201386. 10.1016/j.cell.2015.07.011", "ArticleIdList": ["10.1016/j.cell.2015.07.011", "PMC4556003", "26317466"]}, {"Citation": "Zheng LL, Zhou KR, Liu S, Zhang DY, Wang ZL, Chen ZR, Yang JH, Qu LH. dreamBase: DNA modification, RNA regulation and protein binding of expressed pseudogenes in human health and disease. Nucleic Acids Res. 2018; 46:D85\u201391. 10.1093/nar/gkx972", "ArticleIdList": ["10.1093/nar/gkx972", "PMC5753186", "29059382"]}, {"Citation": "Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45:W98\u2013102. 10.1093/nar/gkx247", "ArticleIdList": ["10.1093/nar/gkx247", "PMC5570223", "28407145"]}, {"Citation": "Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77:e108\u201310. 10.1158/0008-5472.CAN-17-0307", "ArticleIdList": ["10.1158/0008-5472.CAN-17-0307", "PMC6042652", "29092952"]}, {"Citation": "Casper J, Zweig AS, Villarreal C, Tyner C, Speir ML, Rosenbloom KR, Raney BJ, Lee CM, Lee BT, Karolchik D, Hinrichs AS, Haeussler M, Guruvadoo L, et al.. The UCSC Genome Browser database: 2018 update. Nucleic Acids Res. 2018; 46:D762\u201369. 10.1093/nar/gkv1275", "ArticleIdList": ["10.1093/nar/gkv1275", "PMC5753355", "29106570"]}, {"Citation": "Cao Z, Pan X, Yang Y, Huang Y, Shen HB. The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinformatics. 2018; 34:2185\u201394. 10.1093/bioinformatics/bty085", "ArticleIdList": ["10.1093/bioinformatics/bty085", "29462250"]}, {"Citation": "Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014; 42:D92\u201397. 10.1093/nar/gkt1248", "ArticleIdList": ["10.1093/nar/gkt1248", "PMC3964941", "24297251"]}, {"Citation": "Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008; 36:D149\u201353. 10.1093/nar/gkm995", "ArticleIdList": ["10.1093/nar/gkm995", "PMC2238905", "18158296"]}, {"Citation": "Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015; 43:D146\u201352. 10.1093/nar/gku1104", "ArticleIdList": ["10.1093/nar/gku1104", "PMC4383922", "25378301"]}, {"Citation": "Ma Z, Liu T, Huang W, Liu H, Zhang HM, Li Q, Chen Z, Guo AY. MicroRNA regulatory pathway analysis identifies miR-142-5p as a negative regulator of TGF-\u03b2 pathway via targeting SMAD3. Oncotarget. 2016; 7:71504\u201313. 10.18632/oncotarget.12229", "ArticleIdList": ["10.18632/oncotarget.12229", "PMC5342096", "27683030"]}, {"Citation": "Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019; 10:1523. 10.1038/s41467-019-09234-6", "ArticleIdList": ["10.1038/s41467-019-09234-6", "PMC6447622", "30944313"]}]}], "History": [{"Year": "2019", "Month": "7", "Day": "13"}, {"Year": "2019", "Month": "8", "Day": "9"}, {"Year": "2019", "Month": "8", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "31"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31442209", "PMC6738438", "10.18632/aging.102197", "102197"]}}]}